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PLASMA HDL SUBFRACTIONS AND APOPROTEIN A-I AS PREDICTORS 
OF ANGIOGRAPHIC ORONARY DISEASE IN NOHMOLIPIDE?lIC MEN. 
M. Rubenfire, M.D., F.A.C.C., M.J. Goldberg, M.D., 
F.A.C.C. 0 J.J. Maciejkop Ph.D. - Sinai Hospital of Detroit, 
Detroit, Michigan. 
Many patients with coronary artery disease (CAD) have 
desirable levels of total cholesterol (TC) and triglycer- 
ide (TG). We have previously demonstrated that HDL-C, HDL3 
-C, and apoprotein (ape) A-I are inversely correlated with 
the presence of CAD. To determine their predictive values, 
these analytes were assayed in male patients undergoing 
elective coronary arteriography. All had TC and TG levels 
Q25mg/dl, and no history of hypertension or diabetes. Pa- 
tients were categorized as either free of significant CAD 
(~20% obstruction in a coronary artery or branch, n=26) or 
with clinically relevant CAD (yO% obstruction, n=61). 
The Student t test demonstrated the following to be lower 
in the CAD group’: HDL3-C(38+Img/dl vs 32klmg/dl, p~:.OOOl), 
HDL-C(44+2mg/dl vs 37zlmg/dl, pc.01) and apo A-I (lOS+S 
mgfdl vs 99+2mg/dl, pc.03). Linear discriminant analysis 
identified HDL3-C and age to be the most important varia- 
bles for predicting the presence or absence of CAD. Pa- 
tients can be classified as having either normal coronar- 
ies -r clinical CAD using the following equations derived 
from linear discriminant analyses: 
LNormal=-31.00+1.002(HDL3-C)+0.43364(age) 
LCAD=-29.89+0.82303(HDL3-C)+O.S2144(age) 
The larger of the two values obtained after incorporating 
a patients’ age and HDL3-C value into toth equations, 
determines if the patient falls into the normal or CAD 
group. The probability of correctly classifying a patient 
is 69% for the normal group and 80% for the CAD group. 
This sensitivity and specificity makes HDL3-C potentially 
useful in screening normolipidemic patients with chest 
pain for consideration of coronary arteriography to con- 
firm the presence of CAD. 
